Change From Baseline to Weeks 4, 8 & 12 in Mean Number of Incontinence Episodes Per 24 Hours;Change From Baseline in Mean Number of Micturitions Per 24 Hours;Number of Incontinence Episodes Reported During the 3-Day Diary;Change From Baseline in Mean Volume Voided (MVV) Per Micturition;Change From Baseline to EoT in Corrected Micturition Frequency (CMF);Change From Baseline in Mean Number of Urgency Incontinence (UI) Episodes Per 24 Hours;Number of UI Episodes Reported During the 3-Day Diary;Change From Baseline in Mean Number of Urgency Episodes (Grade 3 and/or 4) Per 24 Hours;Change From Baseline in Mean Number of Pads Per 24 Hours;Number of Pads Used During the 3-Day Diary;Change From Baseline in Mean Number of Nocturia Episodes;Number of Nocturia Episodes Reported Over 3-Day Diary;Number of Participants With Change From Baseline to EoT in Euroqol European Quality of Life-5 Dimensions (EQ-5D) Subscale Score: Mobility;Number of Participants With Change From Baseline to EoT in EQ-5D Subscale Score: Self-care;Number of Participants With Change From Baseline to EoT in EQ-5D Subscale Score: Usual Activities;Number of Participants With Change From Baseline to EoT in EQ-5D Subscale Score: Pain/Discomfort;Number of Participants With Change From Baseline to EoT in EQ-5D Subscale Score: Anxiety/Depression;Change From Baseline in Overactive Bladder Symptom (OAB-q) Symptom Bother Score;Change From Baseline in OAB-q Health-Related Quality of Life (HRQL) Total Score;Change From Baseline in OAB-q HRQL Subscale Score: Coping;Change From Baseline in OAB-q HRQL Subscale Score: Concern;Change From Baseline in OAB-q HRQL Subscale Score: Sleep;Change From Baseline in OAB-q HRQL Subscale Score: Social Interaction;Change From Baseline in Treatment Satisfaction - Visual Analogue Scale (TS-VAS) Score;Change From Baseline in Patient Perception Bladder Control (PPBC) Score;Number of Participants in Each Category of Patient and Clinician Global Impression of Change Scales (PGIC and CGIC);Percentage of Participants With at Least a 50% Decrease From Baseline in Mean Number of Incontinence Episodes Per 24 Hours;Percentage of Participants With Zero Incontinence Episodes Postbaseline;Percentage of Participants With a Mean of at Least 8 Micturitions Per 24 Hours at Baseline and Less Than 8 Micturitions Per 24 Hours Postbaseline;Percentage of Participants With at Least a 10-Point Improvement From Baseline in OAB-q Symptom Bother Score;Percentage of Participants With at Least a 10-Point Improvement From Baseline in HRQL Total Score;Percentage of Participants With at Least a 1-Point Improvement From Baseline in PPBC;Percentage of Participants With Major (at Least 2-Point) Improvement From Baseline in PPBC;Number of Participants With Adverse Events (AEs);Change From Baseline in Post Void Residual (PVR) Volume